-
Loading metrics
Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol
- Aashna Karbhari,
- Sherly Mosessian,
- Kamaxi H. Trivedi,
- Frank Valla Jr,
- Mark Jacobson,
- Mark J. Truty,
- Nandakumar G. Patnam,
- Diane M. Simeone,
- Elcin Zan,
- Tracy Brennan
x
- Published: November 27, 2023
- https://doi.org/10.1371/journal.pone.0294564